Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron–Magnesium Supplementation vs Iron Alone for Restless Legs Syndrome in Children
IRCT20180719040526N2Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Iron and magnesium in restless legs syndrome (RLS) (2 arms), sponsored by Qazvin University of Medical Sciences. Started Jun 2026; status: completed.
02
Drugs
Ironmagnesium
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on IRCT20180719040526N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180719040526N2.